Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 42 citing Haymond: Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. (0.08 sec) 

Care of children and adolescents with type 1 diabetes


J Silverstein, G Klingensmith, K Copeland, L … - Diabetes Care, 2005 - care.diabetesjournals.org.p.angrylapdog.com
During recent years, the American Diabetes Association (ADA) has published
detailed guidelines and recommendations for the management of diabetes in the
form of technical reviews, position statements, and consensus statements. ...
Cited by 292 - Related articles - All 24 versions

Glucagon and regulation of glucose metabolism

- physiology.org
G Jiang, BB Zhang - American Journal of Physiology- Endocrinology And …, 2003 - Am Physiological Soc
As a counterregulatory hormone for insulin, glucagon plays a critical role in
maintaining glucose homeostasis in vivo in both animals and humans. To increase
blood glucose, glucagon promotes hepatic glucose output by increasing ...
Cited by 135 - Related articles - BL Direct - All 3 versions

{alpha}-Cells of the endocrine pancreas: 35 years of research but the enigma remains

- endojournals.org
J Gromada, I Franklin, CB Wollheim - Endocrine reviews, 2007 - Endocrine Soc
Glucagon, a hormone secreted from the -cells of the endocrine pancreas, is
critical for blood glucose homeostasis. It is the major counterpart to insulin
and is released during hypoglycemia to induce hepatic glucose output. The ...
Cited by 60 - Related articles - BL Direct - All 4 versions

The role of amylin and glucagon in the dampening of glycemic excursions in children with …

- shouxi.net
RA Heptulla, LM Rodriguez, L Bomgaars, … - Diabetes, 2005 - Am Diabetes Assoc
Postprandial hyperglycemia and preprandial hypoglycemia contribute to poor
glycemic control in type 1 diabetes. We hypothesized that postprandial glycemic
excursions could be normalized in type 1 diabetes by suppressing glucagon ...
Cited by 35 - Related articles - All 10 versions

[PDF] 2: Recent advances in therapy of diabetes


JJ Couper, JB Prins - Medical journal of Australia, 2003 - mja.com.au
THE DISCOVERY OF INSULIN and its introduction as ther- apy for type 1 diabetes
in the early 1920s was understanda- bly thought to have resolved the management
of this fatal disease. However, within a few decades the spectre of ...
Cited by 12 - Related articles - View as HTML - BL Direct - All 4 versions

The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes


LM RODRIGUEZ, KJ MASON, MW HAYMOND … - Pediatric Research, 2007 - journals.lww.com
ABSTRACT: Pramlintide, a synthetic analog of amylin, improves postprandial
hyperglycemia. We compared subcutaneous (sc) pram- lintide injection with square
wave pramlintide infusion in adolescents with type 1 diabetes (T1DM). Eight ...
Cited by 11 - Related articles - BL Direct - All 8 versions

Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: The …


M Hartley, MJ Thomsett, AM Cotterill - Journal of paediatrics and child health, 2006 - interscience.wiley.com
Methods: Data were collected from patients attending the Paediatric Diabetes
Clinic at the Queensland Diabetes Centre at the Mater Hospital, Brisbane in
2002–2004 following the institution of a new protocol for home management ...
Cited by 8 - Related articles - BL Direct - All 4 versions

Hypoglycemia: still the limiting factor in the glycemic management of diabetes


PE Cryer - Endocrine Practice, 2008 - AACE
The clinical manifestations of hypoglycemia are not specific (1,2). Neurogenic
(autonomic) symptoms are the result of the perception of physiologic changes
caused by the sympathoadrenal, largely the sympathetic neural (3), ...
Cited by 7 - Related articles - All 2 versions

Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic …


FH El-Khatib, J Jiang, RG Gerrity, ER … - Diabetes Technology & Therapeutics, 2007 - liebertonline.com
FIRAS H. EL-KHATIB, Ph.D., 1 JOHN JIANG, BS, 1 ROSS G. GERRITY, Ph.D., 2 ...
Background: The objective of this study was to determine the in vivo
pharmacodynamics of glucagon and to test its glycemic effect over days by ...
Cited by 5 - Related articles - BL Direct - All 3 versions

Mini-dose glucagon is effective at diabetes camp


KS Hasan, M Kabbani, R Christensen - The Journal of pediatrics, 2004 - Elsevier
Increased physical activity at camp may result in more frequent and more severe
hypoglycemia in patients who have tight metabolic control in the home setting.
Hypoglycemia may be of variable degree with a severe episode defined by the ...
Cited by 2 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google